Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published ...

Colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related deaths worldwide.

Inhibition of the CSF1-CSF1R axis, a major research direction of macrophage-targeted immunotherapy, led to the depletion of the protective C1QC + macrophage subset while sparing malignant SPP1 ...

Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with ...

Researchers from Moffitt Cancer Center have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study, published ...

However, targeted depletion of suPVMs significantly promoted ... Further investigations confirmed that these structures were ...

Inc., a leading global Contract Research, Development and Manufacturing Organization service company offering end-to-end solutions for biologics discovery, development and manufacturing, is pleased to ...

Their findings, published Thursday in the journal Cell Metabolism, reveal that a cytokine called macrophage migration ... process results in significant fat depletion, contributing to the ...

Macrophage infiltration in various solid tumors is associated ... rendering them potential targets for anticancer therapies through either depletion or reprogramming from a pro-tumoral to an ...